| Literature DB >> 27518562 |
Cristina García-Cáceres1, Carmelo Quarta1, Luis Varela2, Yuanqing Gao1, Tim Gruber1, Beata Legutko1, Martin Jastroch1, Pia Johansson3, Jovica Ninkovic3, Chun-Xia Yi1, Ophelia Le Thuc1, Klara Szigeti-Buck2, Weikang Cai4, Carola W Meyer1, Paul T Pfluger1, Ana M Fernandez5, Serge Luquet6, Stephen C Woods7, Ignacio Torres-Alemán5, C Ronald Kahn4, Magdalena Götz3, Tamas L Horvath2, Matthias H Tschöp8.
Abstract
We report that astrocytic insulin signaling co-regulates hypothalamic glucose sensing and systemic glucose metabolism. Postnatal ablation of insulin receptors (IRs) in glial fibrillary acidic protein (GFAP)-expressing cells affects hypothalamic astrocyte morphology, mitochondrial function, and circuit connectivity. Accordingly, astrocytic IR ablation reduces glucose-induced activation of hypothalamic pro-opio-melanocortin (POMC) neurons and impairs physiological responses to changes in glucose availability. Hypothalamus-specific knockout of astrocytic IRs, as well as postnatal ablation by targeting glutamate aspartate transporter (GLAST)-expressing cells, replicates such alterations. A normal response to altering directly CNS glucose levels in mice lacking astrocytic IRs indicates a role in glucose transport across the blood-brain barrier (BBB). This was confirmed in vivo in GFAP-IR KO mice by using positron emission tomography and glucose monitoring in cerebral spinal fluid. We conclude that insulin signaling in hypothalamic astrocytes co-controls CNS glucose sensing and systemic glucose metabolism via regulation of glucose uptake across the BBB.Entities:
Keywords: astrocytes; glucose uptake; hypothalamus; insulin receptor
Mesh:
Substances:
Year: 2016 PMID: 27518562 PMCID: PMC8961449 DOI: 10.1016/j.cell.2016.07.028
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582